This technique uses plasma rich in growth factors (PRGF), also known as PRP, to treat premature ovarian failure and improve egg quality in women who wish to become pregnant. PRP is a fraction of blood plasma obtained by separating and concentrating platelets through a centrifugation process, which is fully standardised and authorised by the relevant agencies for use as a medicinal product. Platelet-rich plasma is rich in growth factors and bioactive proteins that can stimulate tissue regeneration and repair, as well as the production of new cells.
In this technique, the procedure involves the collection of a small amount of blood from the patient, which is processed to obtain plasma rich in growth factors. This plasma is injected into the patient's ovaries to stimulate tissue regeneration and improve egg quality.
Enhancing ovarian function using PRGF is a promising technique that may help improve egg quality and increase the chances of pregnancy in women with premature ovarian failure. However, it is important to keep in mind that each case is unique and that this treatment may not be suitable for all women and is used as an alternative when other medical options have not been successful.
